MedPath

Comparison of the MRI sequence using different size of fidicual gold marker for intensity modulated radiotherapy for prostate cancer

Phase 1
Conditions
prostate cancer
Registration Number
JPRN-UMIN000019402
Lead Sponsor
Gifu Municipal Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patient who reject our study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To find the ideal Magnetic resonance sequence for localized prostate cancer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath